Brian Silver

7.3k total citations
137 papers, 2.9k citations indexed

About

Brian Silver is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Brian Silver has authored 137 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Epidemiology, 40 papers in Pulmonary and Respiratory Medicine and 37 papers in Neurology. Recurrent topics in Brian Silver's work include Acute Ischemic Stroke Management (78 papers), Cerebrovascular and Carotid Artery Diseases (34 papers) and Stroke Rehabilitation and Recovery (20 papers). Brian Silver is often cited by papers focused on Acute Ischemic Stroke Management (78 papers), Cerebrovascular and Carotid Artery Diseases (34 papers) and Stroke Rehabilitation and Recovery (20 papers). Brian Silver collaborates with scholars based in United States, Canada and Australia. Brian Silver's co-authors include Suresh Patel, Jennifer Simpson, Daniel J. Miller, Louis R. Caplan, Michael D. Hill, Andrew M. Demchuk, Steven R. Levine, Philip A. Barber, Michael Chopp and Gottfried Schlaug and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Brian Silver

130 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Silver United States 30 1.6k 920 754 545 408 137 2.9k
Francisco Purroy Spain 27 1.6k 1.0× 896 1.0× 728 1.0× 349 0.6× 249 0.6× 131 2.6k
Gisele Sampaio Silva Brazil 26 1.8k 1.1× 818 0.9× 1.0k 1.4× 809 1.5× 386 0.9× 151 3.3k
Nerses Sanossian United States 35 2.4k 1.5× 1.2k 1.3× 1.3k 1.7× 626 1.1× 554 1.4× 163 3.9k
PN Sylaja India 26 1.7k 1.1× 949 1.0× 786 1.0× 715 1.3× 341 0.8× 122 2.5k
Simona Ferioli United States 24 1.7k 1.0× 869 0.9× 675 0.9× 652 1.2× 344 0.8× 77 2.8k
Leonard L.L. Yeo Singapore 26 1.3k 0.8× 780 0.8× 987 1.3× 325 0.6× 416 1.0× 210 2.6k
Christine Roffe United Kingdom 31 1.2k 0.8× 684 0.7× 997 1.3× 652 1.2× 191 0.5× 113 3.2k
Byung‐Chul Lee South Korea 32 1.3k 0.8× 837 0.9× 643 0.9× 443 0.8× 222 0.5× 168 2.9k
Christopher S. Coffey United States 32 1.9k 1.2× 900 1.0× 1.8k 2.4× 479 0.9× 492 1.2× 71 4.5k
Mandip S. Dhamoon United States 24 1.1k 0.7× 442 0.5× 550 0.7× 507 0.9× 212 0.5× 133 2.3k

Countries citing papers authored by Brian Silver

Since Specialization
Citations

This map shows the geographic impact of Brian Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Silver more than expected).

Fields of papers citing papers by Brian Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Silver. The network helps show where Brian Silver may publish in the future.

Co-authorship network of co-authors of Brian Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Silver. A scholar is included among the top collaborators of Brian Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Silver. Brian Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jun-O’Connell, Adalia, et al.. (2023). Stroke nurse navigator utilization reduces unplanned 30-day readmission in stroke patients treated with thrombolysis. Frontiers in Neurology. 14. 1205487–1205487. 3 indexed citations
2.
Goldstein, Eric & Brian Silver. (2022). Switching from Alteplase to Tenecteplase: Time to AcT?. SHILAP Revista de lepidopterología. 2(5). e000491–e000491. 1 indexed citations
3.
Ghasemi, Mehdi, et al.. (2020). Prevalence of a Multiple Territory Stroke Pattern After Intravenous Thrombolysis. Journal of Stroke and Cerebrovascular Diseases. 29(5). 104700–104700. 1 indexed citations
4.
Mossavar‐Rahmani, Yasmin, Victor Kamensky, JoAnn E. Manson, et al.. (2019). Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative. Stroke. 50(3). 555–562. 92 indexed citations
5.
Silver, Brian, et al.. (2016). Ruptured aneurysms of the intradural artery of adamkiewicz: Angiographic features and treatment options. Clinical Neurology and Neurosurgery. 146. 152–155. 14 indexed citations
6.
Montalvo, Mayra, Matthew Siket, Mahesh Jayaraman, Shadi Yaghi, & Brian Silver. (2016). Advances in the Management of Transient Ischaemic Attack and Stroke. 101–107. 1 indexed citations
7.
Baird, Grayson L., Sandra C. Yan, Shadi Yaghi, et al.. (2016). Comparison of hematoma volume estimates in intracerebral hemorrhage (P1.208). Neurology. 86(16_supplement). 1 indexed citations
8.
Silver, Brian, et al.. (2014). Stroke: posthospital management and recurrence prevention.. PubMed. 420. 28–38. 2 indexed citations
9.
Silver, Brian, et al.. (2013). Antiplatelet therapy to prevent recurrent stroke: Three good options. Cleveland Clinic Journal of Medicine. 80(12). 787–795. 5 indexed citations
10.
Schultz, Lonni, et al.. (2012). Antithrombotic Management of Stroke Patients Before Colonoscopy. Journal of Stroke and Cerebrovascular Diseases. 22(6). 733–736. 3 indexed citations
11.
Wira, Charles R., et al.. (2011). Cardiac Complications in Acute Ischemic Stroke. Western Journal of Emergency Medicine. 12(4). 414–420. 29 indexed citations
12.
Wira, Charles, et al.. (2011). Cardiac Complications in Acute Ischemic Stroke. Western Journal of Emergency Medicine. 12(4). 414–420. 44 indexed citations
13.
Russman, Andrew, et al.. (2010). Moyamoya Syndrome Associated with Graves' Disease: A Case Report and Review of the Literature. Journal of Stroke and Cerebrovascular Diseases. 20(6). 528–536. 36 indexed citations
14.
Demchuk, Andrew M., Michael D. Hill, Philip A. Barber, et al.. (2008). Importance of Leukoaraiosis on CT for Tissue Plasminogen Activator Decision Making: Evaluation of the NINDS rt-PA Stroke Study. Cerebrovascular Diseases. 26(2). 120–125. 57 indexed citations
15.
Zhang, Li, Zhenggang Zhang, Rui Lan Zhang, et al.. (2006). Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Research. 1118(1). 192–198. 109 indexed citations
16.
Jiang, Quan, Zheng Gang Zhang, Guangliang Ding, et al.. (2006). MRI detects white matter reorganization after neural progenitor cell treatment of stroke. NeuroImage. 32(3). 1080–1089. 116 indexed citations
17.
Demaerschalk, Bart M., Brian Silver, José G. Merino, et al.. (2003). Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada. Stroke. 34. 248–249. 7 indexed citations
18.
Silver, Brian, José G. Merino, Edward Wong, et al.. (2003). Effects of thrombolysis for acute stroke in patients with pre-existing disability.. PubMed. 169(3). 193–7. 33 indexed citations
19.
Silver, Brian, et al.. (2001). A reliable new method to estimate >1/3 middle cerebral artery infarction on early computed tomography scan. Stroke. 32. 325–325. 1 indexed citations
20.
Demaerschalk, Bart M., José G. Merino, Brian Silver, et al.. (2000). Intravenous tissue plasminogen activator for acute ischemic stroke in patients ≥80 years old: The London, Canada experience. Stroke. 32. 368–369. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026